Reumatoloxía

2018

1. 2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertension

   Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 6, pp. 870-876

2. 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

   Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 476-479

3. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients

   Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 22-27

4. Adipokines and inflammation: is it a question of weight?

   British Journal of Pharmacology, Vol. 175, Núm. 10, pp. 1569-1579

5. Administration of intra-articular hydrogen sulphide reduces the severity of osteoarthritis in vivo

   Boletín de la Sociedad Española de Hidrología Médica, Núm. 1, pp. 90-91

6. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: Multicentre retrospective study

   Rheumatology (United Kingdom), Vol. 57, Núm. 5, pp. 856-864

7. Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study

   Clinical and Experimental Rheumatology, Vol. 36, Núm. 3, pp. 0382-0388

8. Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study

   Revista Espanola de Cardiologia, Vol. 71, Núm. 3, pp. 170-177

9. Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project

   Reumatologia Clinica, Vol. 14, Núm. 2, pp. 90-96

10. Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks

    Journal of Orthopaedic Research, Vol. 36, Núm. 2, pp. 594-604

11. Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment

    RMD Open, Vol. 4, Núm. 1

12. Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries

    RMD Open, Vol. 4, Núm. 2

13. E74-Like Factor (ELF3) and Leptin, a Novel Loop between Obesity and Inflammation Perpetuating a Pro-Catabolic State in Cartilage

    Cellular Physiology and Biochemistry, Vol. 45, Núm. 6, pp. 2401-2410

14. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)

    Clinical Microbiology and Infection, Vol. 24, pp. S10-S20

15. Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: A phase IIIB, randomised controlled trial (ACTIVE)

    Annals of the Rheumatic Diseases, Vol. 77, Núm. 5, pp. 690-698

16. Efectos anti-catabólicos del sulfuro de hidrógeno en tejido articular artrósico

    Boletín de la Sociedad Española de Hidrología Médica, Núm. 1, pp. 179-180

17. Effect of weight loss on activity in psoriatic arthritis: A systematic review

    Reumatologia Clinica, Vol. 14, Núm. 4, pp. 207-210

18. Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

    The Lancet, Vol. 391, Núm. 10136, pp. 2213-2224

19. Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: A systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis

    RMD Open, Vol. 4, Núm. 2

20. Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

    American Journal of Ophthalmology, Vol. 195, pp. 181-190